Mohammad Fathalipour

A triple‐blind, placebo‐controlled, randomized clinical trial to evaluate the effect of curcumin‐containing nanomicelles on cellular immune responses subtypes and clinical outcome in<scp>COVID</scp>‐19 patients

Mehdi Hassaniazad, Ebrahim Eftekhar, Behnaz Rahnama Inchehsablagh et al. · Phytotherapy Research · 2021 · 82 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial

Ali Ameri, Masoomeh Asadi, Ava Ziaei et al. · Inflammopharmacology · 2022 · 32 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +6

Design, synthesis, and in silico studies of novel eugenyloxy propanol azole derivatives having potent antinociceptive activity and evaluation of their β-adrenoceptor blocking property

Somayeh Behrouz, Mohammad Navid Soltani Rad, Bahareh Taghavi Shahraki et al. · Molecular Diversity · 2018 · 30 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm

Alieh Gholaminejad, Mohammad Fathalipour, Amir Roointan · BMC Nephrology · 2021 · 29 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +17

Caffeic Acid Alkyl Amide Derivatives Ameliorate Oxidative Stress and Modulate ERK1/2 and AKT Signaling Pathways in a Rat Model of Diabetic Retinopathy

Mohammad Fathalipour, Masoomeh Eghtedari, Fernanda Borges et al. · Chemistry & Biodiversity · 2019 · 19 citations

Medicine, Ophthalmology, Pharmacology +16